FTBI

DRUG2 trials

Sponsors

Stanford University

Conditions

Acute GVHDAcute-graft-versus-host DiseaseHematologic DiseasesHodgkin LymphomaLeukemiaLymphoma, Non-HodgkinNon-Hodgkin Lymphoma (NHL)

Phase 2

Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

CompletedNCT00350181

Stanford UniversityAcute GVHD, Hematologic Diseases, Leukemia +1

Start: 2006-08-31End: 2010-04-30Updated: 2021-09-23

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

TerminatedNCT01220297

Stanford UniversityAcute-graft-versus-host Disease, Hematologic Diseases, Hodgkin Lymphoma +2

Start: 2006-08-31End: 2011-08-31Updated: 2017-06-05